PhaseBio(美国)

PhaseBio

美国PhaseBiowww.phasebio.com作为一家开发治疗糖尿病、代谢性疾病和心血管疾病等药物临床阶段的生物技术私人企业——PhaseBio药物有限公司PhaseBioisaclinical-stagebiopharmaceuticalcompanycommittedtodevelopingnewandimproveddrugswithaninitialfocus onendocrine,metabolicandcardiovasculardisease.Thecompanyusesaproprietaryclassofrecombinantbiopolymerscalledelastin-likepolymers(ELPs)toimprovethestability,bioavailability,activityandeaseofadministrationofproteinsandpeptidesthathavebeenshowntobeclinicallyactivewiththegoalofachievinggreaterdrugpotency,fewersideeffectsandbetterpatientcompliance.TheELPtechnologywasfirstdevelopedbyAshutoshChilkoti,Ph.D.,ProfessorofBiomedicalEngineeringatDukeUniversityandfurtherenhancedbyPhaseBioscientiststocreatelongactingbiopharmaceuticals.PhaseBiohastwoleadprograms.OurfirstleadcandidateGlymera,iscurrentlybeingevaluatedinhumansforthetreatmentofhyp